Dalcetrapib reduces risk of new-onset diabetes in patients with coronary heart disease

<p><strong>Objective</strong> Incident type 2 diabetes is common among patients with recent acute coronary syndrome and is associated with an adverse prognosis. Some data suggest that cholesteryl ester transfer protein (CETP) inhibitors reduce incident type 2 diabetes. We compared...

全面介紹

書目詳細資料
Main Authors: Schwartz, GG, Leiter, LA, Ballantyne, CM, Preiss, D, Et al.
格式: Journal article
語言:English
出版: American Diabetes Association 2020

相似書籍